Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POPCUR: Curcumin vs Placebo for Post-op Recurrence in Crohn's Disease
NCT02255370Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Dec 2014
- Primary completion
- Nov 2017
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of curcumin in Crohn's disease, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Started Dec 2014; status: completed.
02
Drugs
curcumin
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT02255370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02255370.